Silo Pharma files patent for ibogaine treatment targeting brain injury

Go back to Silo Pharma files patent for ibogaine treatment targeting brain injury
(NASDAQ: SILO) Delayed: 6.04 -0.08 (1.31%)
Previous Close $6.12    52 Week High
Open $6.12    52 Week Low
Day High $6.37    P/E N/A 
Day Low $5.93    EPS
Volume 20,706